Nobivac Feline 1-HCP+FeLV

Dosage and Administration:

Transfer contents of the Nobivac^® FeLV vial to the Nobivac^® Feline 1-HCP vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Prior To Use, Warm The Nobivac® FeLV Vaccine To Room Temperature And Shake Well.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

Revaccinate every two years with a single dose of Nobivac^® Feline 1-HCP + FeLV. Revaccination in the intervening years with Nobivac^® Feline 1-HCP is recommended.

Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Studies indicate that cats vaccinated with Nobivac^® Feline 1-HCP + FeLV are protected against persistent FeLV viremia for at least two years after vaccination.

Precautions:

Store at 2° - 7°C.
Do not freeze.
Do not mix with other vaccines.
Use new, non-chemically sterilized needles and syringes.
Burn vaccine container and all unused contents.

Warnings:

Contains gentamicin and amphotericin B as preservatives.
Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
Do not vaccinate pregnant cats.
The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote:

Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following FeLV vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination may not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.

Intervet Inc., Omaha, NE 68103 USA
U.S. Veterinary License No. 165A
1 800 224-5318 (USA)
1 888 306-0069 (Canada)
© 1999, 2009 Intervet Inc.
All rights reserved.

Presentation:
25 x 1 Dose

Nac No.
10470505
INTERVET INC., MERCK ANIMAL HEALTH
556 MORRIS AVE., SUMMIT, NJ, 07901
Telephone: 908-473-5552
Order Desk: 800-648-2118
Fax: 908-473-5560
Customer Service: 800-521-5767

Modified Live Virus
This vaccine and all others containing live viruses require a written prescription to ship to the state of Minnesota.